1143P Nivolumab and ipilimumab (N+I) is active in patients (pts) with metastatic uveal melanoma (mUM) with extra-hepatic only involvement: Pooled analysis from 2 phase II trials
暂无分享,去创建一个
C. Tebé | E. Espinosa | A. Joshua | J. Rodriguez | A. Berrocal | L. Khoja | M. Pelster | S. Patel | L. Merino